| RS2148058081 |
PHKA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease IXa1, Glycogen storage disease IXa1 |
| RS2148058653 |
KDM6A
|
Health Risk |
Pathogenic |
Kabuki syndrome 2, Thyroid cancer |
| RS2148058668 |
KDM6A
|
Health Risk |
Pathogenic |
Kabuki syndrome 2, Kabuki syndrome 2 |
| RS2148059524 |
NBAS
|
Health Risk |
Pathogenic |
— |
| RS2148060260 |
CAD
|
Health Risk |
Likely pathogenic |
— |
| RS2148060407 |
OTOF
|
Health Risk |
Pathogenic |
Bilateral sensorineural hearing impairment, Bilateral sensorineural hearing impairment |
| RS2148060432 |
OTOF
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 9, Autosomal recessive nonsyndromic hearing loss 9 |
| RS2148061633 |
RYR2
|
Health Risk |
Likely pathogenic |
— |
| RS2148063184 |
CAD
|
Health Risk |
Pathogenic |
— |
| RS2148066296 |
ODC1
|
Health Risk |
Pathogenic |
— |
| RS2148066893 |
SRD5A2
|
Health Risk |
Pathogenic |
3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency, 3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency |
| RS2148069969 |
GBA1
|
Health Risk |
Likely pathogenic |
— |
| RS2148070287 |
GBA1
|
Health Risk |
Pathogenic |
Gaucher disease, Gaucher disease |
| RS2148070579 |
GBA1
|
Health Risk |
Pathogenic |
Gaucher disease, Gaucher disease |
| RS2148071537 |
GBA1
|
Health Risk |
Pathogenic |
Gaucher disease perinatal lethal, Gaucher disease perinatal lethal |
| RS2148073370 |
GBA1
|
Health Risk |
Pathogenic |
Gaucher disease, Gaucher disease |
| RS2148075419 |
GBA1
|
Health Risk |
Pathogenic |
Gaucher disease, Gaucher disease |
| RS2148075570 |
GBA1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2148076506 |
GBA1
|
Health Risk |
Likely pathogenic |
— |
| RS2148078325 |
CAD
|
Health Risk |
Pathogenic |
— |
| RS2148078546 |
OTOF
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 9, Autosomal recessive nonsyndromic hearing loss 9 |
| RS2148079453 |
GBA1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2148079606 |
GBA1
|
Health Risk |
Likely pathogenic |
— |
| RS2148080342 |
CAD
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 50 |
| RS2148089318 |
XIAP
|
Health Risk |
Pathogenic |
X-linked lymphoproliferative disease due to XIAP deficiency, X-linked lymphoproliferative disease due to XIAP deficiency |
| RS2148089574 |
XIAP
|
Health Risk |
Likely pathogenic |
— |
| RS2148089962 |
XIAP
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked lymphoproliferative disease due to XIAP deficiency, X-linked lymphoproliferative disease due to XIAP deficiency |
| RS2148090158 |
XIAP
|
Health Risk |
Pathogenic |
X-linked lymphoproliferative disease due to XIAP deficiency, X-linked lymphoproliferative disease due to XIAP deficiency |
| RS2148090201 |
XIAP
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked lymphoproliferative disease due to XIAP deficiency, X-linked lymphoproliferative disease due to XIAP deficiency |
| RS2148090291 |
XIAP
|
Health Risk |
Likely pathogenic |
Autoinflammatory syndrome, Autoinflammatory syndrome |
| RS2148090502 |
NBAS
|
Health Risk |
Pathogenic |
Short stature-optic atrophy-Pelger-Huët anomaly syndrome, Short stature-optic atrophy-Pelger-Huët anomaly syndrome |
| RS2148090735 |
ATRX
|
Health Risk |
Likely pathogenic |
Intellectual disability-hypotonic facies syndrome, X-linked |
| RS2148092534 |
CAD
|
Health Risk |
Pathogenic |
— |
| RS2148092759 |
XIAP
|
Health Risk |
Pathogenic |
X-linked lymphoproliferative disease due to XIAP deficiency, X-linked lymphoproliferative disease due to XIAP deficiency |
| RS2148092792 |
XIAP
|
Health Risk |
Pathogenic |
X-linked lymphoproliferative disease due to XIAP deficiency, X-linked lymphoproliferative disease due to XIAP deficiency |
| RS2148093265 |
PCNT
|
Health Risk |
Likely pathogenic |
Microcephalic osteodysplastic primordial dwarfism type II, Microcephalic osteodysplastic primordial dwarfism type II |
| RS2148093442 |
PCNT
|
Health Risk |
Pathogenic |
Microcephalic osteodysplastic primordial dwarfism type II, Microcephalic osteodysplastic primordial dwarfism type II |
| RS2148096152 |
XIAP
|
Health Risk |
Pathogenic |
X-linked lymphoproliferative disease due to XIAP deficiency, Nonpapillary renal cell carcinoma |
| RS2148096182 |
XIAP
|
Health Risk |
Pathogenic |
X-linked lymphoproliferative disease due to XIAP deficiency, X-linked lymphoproliferative disease due to XIAP deficiency |
| RS2148097889 |
XIAP
|
Health Risk |
Likely pathogenic |
X-linked lymphoproliferative disease due to XIAP deficiency, Thyroid cancer |
| RS2148100379 |
FLNA
|
Health Risk |
Pathogenic |
Patent foramen ovale, Dysplastic corpus callosum |
| RS2148100720 |
FOSL2
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2148101204 |
FLNA
|
Health Risk |
Pathogenic |
HETEROTOPIA, PERIVENTRICULAR NODULAR |
| RS2148101228 |
FLNA
|
Health Risk |
Pathogenic |
Heterotopia, periventricular |
| RS2148102202 |
FLNA
|
Health Risk |
Likely pathogenic |
Oto-palato-digital syndrome, type II |
| RS2148102210 |
FLNA
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2148102297 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Heterotopia, periventricular |
| RS2148102743 |
DEPDC5
|
Health Risk |
Likely pathogenic |
Familial focal epilepsy with variable foci, Inborn genetic diseases |
| RS2148102980 |
FLNA
|
Health Risk |
Likely pathogenic |
Frontometaphyseal dysplasia, Oto-palato-digital syndrome |
| RS2148103004 |
FLNA
|
Health Risk |
Pathogenic |
Melnick-Needles syndrome, Heterotopia |
| RS2148103087 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2148103123 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2148103177 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2148103243 |
DEPDC5
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2148103458 |
FLNA
|
Health Risk |
Pathogenic |
Melnick-Needles syndrome, Heterotopia |
| RS2148103774 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2148103917 |
FLNA
|
Health Risk |
Pathogenic |
Melnick-Needles syndrome, Frontometaphyseal dysplasia |
| RS2148104272 |
FLNA
|
Health Risk |
Likely pathogenic |
Attenuated frontometaphyseal dysplasia, Attenuated frontometaphyseal dysplasia |
| RS2148104376 |
FLNA
|
Health Risk |
Likely pathogenic |
Heterotopia, periventricular |
| RS2148104615 |
FLNA
|
Health Risk |
Pathogenic |
Melnick-Needles syndrome, Frontometaphyseal dysplasia |
| RS2148104651 |
FLNA
|
Health Risk |
Pathogenic |
Heterotopia, periventricular |
| RS2148104758 |
FLNA
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS2148104977 |
FLNA
|
Health Risk |
Pathogenic |
— |
| RS2148105341 |
FLNA
|
Health Risk |
Likely pathogenic |
Macrothrombocytopenia, Macrothrombocytopenia |
| RS2148105583 |
FLNA
|
Health Risk |
Pathogenic |
— |
| RS2148106461 |
FLNA
|
Health Risk |
Pathogenic |
Abnormal cerebral morphology, Abnormal cerebral morphology |
| RS2148106783 |
TAF1
|
Health Risk |
Likely pathogenic; association |
Intellectual disability, X-linked |
| RS2148107375 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS2148107380 |
FLNA
|
Health Risk |
Likely pathogenic |
Melnick-Needles syndrome, Melnick-Needles syndrome |
| RS2148107418 |
FLNA
|
Health Risk |
Pathogenic |
— |
| RS2148107447 |
SRD5A2
|
Health Risk |
Conflicting classifications of pathogenicity |
3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency, 3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency |
| RS2148107588 |
FLNA
|
Health Risk |
Likely pathogenic |
— |
| RS2148111202 |
FLNA
|
Health Risk |
Pathogenic |
Melnick-Needles syndrome, Heterotopia |
| RS2148111417 |
FLNA
|
Health Risk |
Pathogenic |
Melnick-Needles syndrome, Frontometaphyseal dysplasia |
| RS2148111675 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Oto-palato-digital syndrome, type II |
| RS2148112023 |
CHM
|
Health Risk |
Pathogenic |
— |
| RS2148112149 |
XIAP
|
Health Risk |
Pathogenic |
X-linked lymphoproliferative disease due to XIAP deficiency, X-linked lymphoproliferative disease due to XIAP deficiency |
| RS2148112156 |
XIAP
|
Health Risk |
Likely pathogenic |
X-linked lymphoproliferative disease due to XIAP deficiency, X-linked lymphoproliferative disease due to XIAP deficiency |
| RS2148112215 |
XIAP
|
Health Risk |
Pathogenic |
X-linked lymphoproliferative disease due to XIAP deficiency, X-linked lymphoproliferative disease due to XIAP deficiency |
| RS2148113604 |
FLNA
|
Health Risk |
Pathogenic |
Oto-palato-digital syndrome, type II |
| RS2148113628 |
FLNA
|
Health Risk |
Pathogenic |
Melnick-Needles syndrome, Frontometaphyseal dysplasia |
| RS2148113975 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Oto-palato-digital syndrome, type II |
| RS2148114051 |
FLNA
|
Health Risk |
Pathogenic |
Heterotopia, periventricular |
| RS2148114607 |
FLNA
|
Health Risk |
Likely pathogenic |
Heterotopia, periventricular |
| RS2148115298 |
PCNT
|
Health Risk |
Pathogenic |
Microcephalic osteodysplastic primordial dwarfism type II, Microcephalic osteodysplastic primordial dwarfism type II |
| RS2148115776 |
FLNA
|
Health Risk |
Pathogenic |
Melnick-Needles syndrome, Frontometaphyseal dysplasia |
| RS2148115834 |
FLNA
|
Health Risk |
Likely pathogenic |
Heterotopia, periventricular |
| RS2148116120 |
CASK
|
Health Risk |
Pathogenic |
Intellectual disability, CASK-related |
| RS2148116288 |
FLNA
|
Health Risk |
Pathogenic |
Melnick-Needles syndrome, Heterotopia |
| RS2148117604 |
KDM6A
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome 2, Kabuki syndrome 2 |
| RS2148118072 |
FLNA
|
Health Risk |
Pathogenic |
Oto-palato-digital syndrome, type II |
| RS2148118126 |
FLNA
|
Health Risk |
Pathogenic/Likely pathogenic |
Melnick-Needles syndrome, Frontometaphyseal dysplasia |
| RS2148118664 |
KDM6A
|
Health Risk |
Pathogenic |
— |
| RS2148118942 |
FLNA
|
Health Risk |
Pathogenic |
Melnick-Needles syndrome, Frontometaphyseal dysplasia |
| RS2148118964 |
FLNA
|
Health Risk |
Pathogenic |
Melnick-Needles syndrome, Frontometaphyseal dysplasia |
| RS2148119164 |
FLNA
|
Health Risk |
Pathogenic |
Oto-palato-digital syndrome, type II |
| RS2148119182 |
FLNA
|
Health Risk |
Pathogenic |
Oto-palato-digital syndrome, type II |
| RS2148119316 |
FLNA
|
Health Risk |
Likely pathogenic |
Melnick-Needles syndrome, Frontometaphyseal dysplasia |
| RS2148119354 |
FLNA
|
Health Risk |
Pathogenic |
Melnick-Needles syndrome, Frontometaphyseal dysplasia |
| RS2148119399 |
FLNA
|
Health Risk |
Likely pathogenic |
See cases, See cases |